No, that isn't cleaned up - in 3 weeks the 2020 10-k is due - Deitsch should have filed an 8-K concerning the investor(s) who purchased the toxic debt - but there isn't any proof that the toxic debt was purchased and if it was purchased we don't know the terms and conditions of the purchase and if the investors received convertible notes.
Deitsch has been living off of toxic financing for many years and that has caused massive dilution.
But the question becomes - why didn't Deitsch file any financial information since 09/30/2018 until he recently filed the 2018 10-K.
"So you mean by the time they regain SEC compliance, they will be trading .10?
No debt, fully funded, patents renewed, auditors hired, SEC lawyers hired, IP attorneys hired, manufacturing busy, warehouse busy, shipping and packing busy, lab busy, collaboration with government agencies, selling on Amazon, Walmart, and etc, new distributors, all these not fitting in your “cleaned up” description?"
First, you don't know if there isn't any debt.
Let's take a closer look at just one patent:
11/642,312 USE OF COBRATOXIN AS AN ANALGESIC
The patent was recorded on 03-08-2011 and the patent hasn't been licensed and generated very little revenue.
You don't know anything about the manufacturing - I don't believe Nutra is manufacturing the products sold on Amazon and Walmart.com.
There isn't any brand awareness so the sales from Amazon and Walmart.com are minimal at best.
So, no that isn't cleaning up the shell.
The O/S is out of control.
IG
News 
Market Data 
Discover 
